Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study. Lee C, Park JW, Kim YD, Woo KI, et al. Int Ophthalmol 2024;44:179.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee C, Park JW, Kim YD, Woo KI, et al. Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study. Int Ophthalmol 2024;44:179.
PMID: 38622479